Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere

Michel Souchet1, Elodie Portales-Casamar, David Mazurais

  • 1SmithKline Beecham Laboratoires Pharmaceutiques, Unité de Biologie Cardiovasculaire, 4 rue du Chesnay Beauregard, BP 96205, 35760 Saint-Grégoire, France.

Journal of Cell Science
|February 28, 2002
PubMed

Insights

Researchers identified p63RhoGEF, a novel guanine nucleotide exchange factor (GEF), that specifically activates RhoA. This protein plays a key role in regulating the actin cytoskeleton, particularly in heart cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cardiovascular Research

Background:

  • Rho small GTPases are critical regulators of cellular signaling pathways.
  • Dysregulation of Rho GTPases is linked to cardiovascular disorders.
  • Novel modulators of Rho GTPases are sought for therapeutic and research purposes.

Purpose of the Study:

  • To identify and characterize novel modulators of Rho GTPases.
  • To investigate the function and localization of the newly discovered p63RhoGEF.
  • To explore the role of p63RhoGEF in cellular morphology and cardiovascular health.

Main Methods:

  • Northern blot and in situ hybridization for gene expression analysis.
  • In vitro guanine nucleotide exchange assays to determine GEF activity.
  • Cell-based assays (stress fiber formation) and immunocytochemistry for protein localization.

Main Results:

  • p63RhoGEF is a novel Db1-like guanine nucleotide exchange factor (GEF).
  • p63RhoGEF is primarily expressed in the heart and brain.
  • p63RhoGEF specifically activates RhoA, leading to actin cytoskeleton reorganization.
  • p63RhoGEF is localized to the sarcomeric I-band in human heart tissue.

Conclusions:

  • p63RhoGEF is a RhoA-specific GEF with a significant role in actin cytoskeleton dynamics.
  • p63RhoGEF may be crucial for maintaining cardiac cellular morphology and function.
  • Further research into p63RhoGEF could offer insights into cardiovascular disorders.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...